Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.
OBJECTIVE
As part of a long-term, relapse-prevention study of antidepressant versus mood stabilizer monotherapy of bipolar II major depressive episode, we prospectively examined the efficacy and mood conversion rate of initial fluoxetine monotherapy. We hypothesized that there would be a statistically significant reduction in depressive symptoms without a clinically meaningful increase in mood conversion symptoms.


METHODS
Patients received open-label fluoxetine monotherapy 10 to 80 mg daily for up to 14 weeks. Primary outcome was change over time in Hamilton Depression Rating score, with secondary outcomes including the proportion of treatment responders and remitters, change over time in Young Mania Rating Scale (YMRS) score, and frequency of mood conversion episodes.


RESULTS
One hundred forty-eight patients had at least 1 post-baseline measurement. Mean Hamilton Depression Rating score decreased by 9.0 points (P < 0.0005). There were 88 responder patients (59.5%; 95% confidence interval [CI], 51.1%-67.4%) (P < 0.0005) and 86 remitter patients (58.1%; 95% CI, 49.7%-66.2%) (P < 0.0005). Mean time to remission was 64.4 days (95% CI, 59.1-69.7 days). Six patients (4.1%; 95% CI, 1.5%-8.6%) (P < 0.0005) had hypomania, and 29 patients (19.6%; 95% CI, 13.5%-26.9%) (P < 0.0005) had subsyndromal hypomania, which did not result in treatment discontinuation. Six patients (4.1%; 95% CI, 1.5%-8.6%) had a YMRS score of 8 or greater (P < 0.0005), and 4 patients (2.7%; 95% CI, 0.7%-6.8%) (P < 0.0005) had a YMRS score of 12 or greater at any study visit.


CONCLUSIONS
Although design limitations constrain the interpretation of the current findings, fluoxetine monotherapy may be an effective short-term treatment of bipolar II major depressive episode with a relatively low rate of syndromal hypomanic episodes.
Amsterdam
Jay D
JD
Depression Research Unit, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. jamsterd@mail.med.upenn.edu
Shults
Justine
J
D000328:Adult; D000339:Affect / Q000187:drug effects*; D000368:Aged; D000369:Aged, 80 and over; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology*; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
D005473:Fluoxetine
J Clin Psychiatry. 2001 Aug;62(8):612-6
11561933
J Clin Psychiatry. 2001 Dec;62(12):985-90
11780881
Am J Psychiatry. 1998 Sep;155(9):1247-53
9734550
J Affect Disord. 2005 Feb;84(2-3):209-17
15708418
J Affect Disord. 2005 May;86(1):1-10
15820265
J Clin Psychiatry. 1996;57 Suppl 12A:3-88
8946806
J Clin Psychiatry. 2000 Oct;61(10):804-8; quiz 809
11078046
J Clin Psychopharmacol. 1991 Feb;11(1):52-4
2040716
Bipolar Disord. 2003 Oct;5(5):310-9
14525551
Bipolar Disord. 2004 Feb;6(1):75-81
14996144
Int Clin Psychopharmacol. 2005 Sep;20(5):257-64
16096516
J Clin Psychopharmacol. 1998 Dec;18(6):435-40
9864074
N Engl J Med. 2007 Apr 26;356(17):1711-22
17392295
Int Clin Psychopharmacol. 1989 Oct;4(4):313-22
2607128
Am J Psychiatry. 2006 Feb;163(2):232-9
16449476
Bipolar Disord. 2003 Dec;5(6):421-33
14636365
J Clin Psychiatry. 1994 Sep;55(9):391-3
7929019
Arch Gen Psychiatry. 1988 Aug;45(8):742-7
3395203
J Clin Psychiatry. 2007 Oct;68(10):1472-9
17960960
Acta Psychiatr Scand. 2008 Nov;118(5):347-56
18727689
J Clin Psychopharmacol. 2008 Apr;28(2):171-81
18344727
Br J Psychiatry. 1978 Nov;133:429-35
728692
Am J Psychiatry. 1994 Dec;151(12 Suppl):1-36
7977902
Bipolar Disord. 2003 Dec;5(6):407-20
14636364
J Affect Disord. 2009 Jan;112(1-3):219-30
18486235
Arch Gen Psychiatry. 1998 Jan;55(1):23-5
9435756
Am J Psychiatry. 2002 Apr;159(4 Suppl):1-50
11958165
Biol Psychiatry. 2000 Sep 15;48(6):558-72
11018227
Can J Psychiatry. 1997 Aug;42 Suppl 2:87S-91S
9288441